# Oral absorption of semaglutide: pharmacokinetic modeling and molecular dynamics simulations.

> PubMed lists PMID 40686549 in In silico pharmacology as Journal Article, with publication-date metadata of 2025-07-16 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-40686549-semaglutide:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-07-26
- Source checked: 2026-08-10
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-40686549-semaglutide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-40686549-semaglutide-v1.json
- Content SHA-256: `22601a9a7a7caedcc8a2965c65d2cf164328e9cd4d1d183230d3e6bd27abbf49`

## Claims and source pins

### Headline

Oral absorption of semaglutide: pharmacokinetic modeling and molecular dynamics simulations. ([`pubmed-observation-pmid-40686549-2026-07-26-6a6c1eb0c3b8`](#source-pubmed-observation-pmid-40686549-2026-07-26-6a6c1eb0c3b8))

### Summary

PubMed lists PMID 40686549 in In silico pharmacology as Journal Article, with publication-date metadata of 2025-07-16 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-40686549-2026-07-26-6a6c1eb0c3b8`](#source-pubmed-observation-pmid-40686549-2026-07-26-6a6c1eb0c3b8))

### Paragraph 1

PubMed lists PMID 40686549 in In silico pharmacology as Journal Article, with publication-date metadata of 2025-07-16 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-40686549-2026-07-26-6a6c1eb0c3b8`](#source-pubmed-observation-pmid-40686549-2026-07-26-6a6c1eb0c3b8))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-40686549-2026-07-26-6a6c1eb0c3b8`](#source-pubmed-observation-pmid-40686549-2026-07-26-6a6c1eb0c3b8))

## Sources

<a id="source-pubmed-observation-pmid-40686549-2026-07-26-6a6c1eb0c3b8"></a>
- **Oral absorption of semaglutide: pharmacokinetic modeling and molecular dynamics simulations. · retained source version 1:2026-07-26:current:6a6c1eb0c3b8fc830a88387c71bd20250ed4e0fe35a894df6f10a0c44aacd161** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/40686549/) (`pubmed-observation-pmid-40686549-2026-07-26-6a6c1eb0c3b8`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Oral absorption of semaglutide: pharmacokinetic modeling and molecular dynamics simulations." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-40686549-semaglutide-v1.json SHA-256: 22601a9a7a7caedcc8a2965c65d2cf164328e9cd4d1d183230d3e6bd27abbf49.